Molecular Mechanisms, Biomarker Value, and Advances in Targeted Therapy for Core Pathological Targets in Alzheimer’s Disease
Alzheimer’s disease is jointly driven by Aβ deposition, Tau abnormalities, neuroinflammation, disrupted lipid metabolism, and synaptic injury. Defining the core targets at different pathological stages provides the basis for disease stratification, therapeutic monitoring, and the design of ...
危险品化学品经营许可证（带存储）